Archives

Use the basic search or click on advanced for more search options.

Advanced Search Basic Search Advanced Search

Publications

Section

Select publication to see the relevant sections.

Publication Date

    E.g., 2018-10-16
    E.g., 2018-10-16

Archive Search

3 results
12:00 AM, Jul 14, 2014  |  BC Week In Review | Clinical News  |  Regulatory

L-Cartin Free Form regulatory update

the product as an oral solution and injection. The product is an unchlorinated form of levocarnitine
12:00 AM, Apr 13, 2009  |  BC Week In Review | Company News  |  Deals

Sigma-Tau S.p.A., Danisco deal

Sigma-Tau focuses on the development and commercialization of products for rare diseases, including its marketed Carnitor
levocarnitine to prevent and treat carnitine deficiency in patients with end stage renal disease undergoing dialysis …
12:00 AM, Jan 04, 2000  |  BC Week In Review | Clinical News  |  Regulatory

Carnitor levocarnitine injection regulatory update

The FDA granted marketing approval to Sigma-Tau subsidiary Sigma-Tau Pharmaceuticals Inc. (Gaithersburg, Md.) for Carnitor injection …
patients with end stage renal disease undergoing dialysis. Sigma-Tau S.p.A. , Rome, Italy   Product: Carnitor